30 records matched your query
04025cam a22004934a 4500 001 426AC4002B0B11DE9A033608A8D7520A 005 20150520012456 008 050428s2005 enka b 001 0 eng 010 $a 2005012018 020 $a 9780521854962 020 $a 0521854962 035 $a (OCoLC)60028983 040 $a DLC $c DLC $d SILO $d BAKER $d VVC $d NLM $d IXA $d LUI $d SILO 050 00 $a HD9665.5 $b .E85 2005 060 00 $a 2005 O-341 060 10 $a QV 736 $b E848 2005 082 00 $a 338.4/76151 $2 22 245 0 $a Ethics and the pharmaceutical industry / $c edited by Michael A. Santoro, Thomas M. Gorrie. 260 $a New York, NY : $a New York, NY : $b Cambridge University Press, $c 2005. 300 $a xxxiv, 492 p. : $b ill. ; $c 24 cm. 504 $a Includes bibliographical references and index. 505 0 $a Drug research: between ethical demands and economic constraints / JuÌrgen Drews -- Emerging international norms for clinical testing: good clinical trial practice / Juhana E. IdaÌnpaÌaÌn-HeikkilaÌ, Sev Fluss -- The regulatory and ethical challenges of pediatric research / M. Dianne Murphy, Sara F. Goldkind -- Including children in research: participation or exploitation? / Robert M. Nelson -- Racial and ethnic inclusiveness in clinical trials / Valentine J. Burroughs -- The rights of patients to participate in clinical research / Glenna M. Crooks -- How should government regulate stem-cell research? views from a scientist-legislator / Rush Holt -- Ethics and prescribing: the clinician's perspective / Charles L. Bardes -- The regulation of prescription drug promotion / Thomas Abrams -- 505 0 $a Direct-to-consumer advertising of prescription drugs: a policy dilemma / Meredith B. Rosenthal, Julie M. Donohue -- Off-label communications and prescription drugs / Schott D. Danzis -- The need for better health information: advancing the informed patient in Europe / Don E. Detmer, Peter Singleton, Scott C. Ratzan -- Who should get access to which drugs? an ethical template for pharmacy benefits / Norman Daniels, James E. Sabin, J. Russell Teagarden -- The application of cost-effectiveness and cost-benefit analysis to pharmaceuticals / Joel W. Hay -- Intellectual property rights, access to life-enhancing drugs, and corporate moral responsibilities / Patricia H. Werhande, Michael E. Gorman -- 505 0 $a A future agenda for government-industry relations / William C. Weldon -- AIDS activism and the pharmaceutical industry / Martin Delaney -- The campaign against innovation / Sidney Taurel -- Third world perspectives on global pharmaceutical access / James Thuo Gathii -- The promise of vaccines and the influenza vaccine shortage of 2004: public and private partnerships / Gary R. Noble -- Evolving approaches to healthcare challenges / Thomas M. Gorrie -- Property rights in crisis: managers and rescue / Nien-heÌ Hsieh -- Blurring the lines: public and private partnerships addressing global health / William H. Foege -- Renegotiating the grand bargain: balancing prices, profits, people, and principles / Edward Greg Koski. 650 0 $a Pharmaceutical industry. 650 0 $a Drugs $x Moral and ethical aspects. $x Moral and ethical aspects. 650 0 $a Drugs $x Moral and ethical aspects. $x Moral and ethical aspects. 650 0 $a Medical innovations $x Social aspects. 650 0 $a Social responsibility of business. 650 12 $a Drug Industry $x ethics. 650 12 $a Drug Industry $x organization & administration. 650 22 $a Ethics, Business. 650 22 $a Social Responsibility. 650 22 $a Technology, Pharmaceutical $x ethics. 700 1 $a Santoro, Michael A. 700 1 $a Gorrie, Thomas M. 856 41 $3 Table of contents $u http://www.loc.gov/catdir/toc/ecip0511/2005012018.html 939 $a 5551353 941 $a 3 952 $l OVUX522 $d 20171230012022.0 952 $l USUX851 $d 20160823070731.0 956 $a http://locator.silo.lib.ia.us/search.cgi?index_0=id&term_0=426AC4002B0B11DE9A033608A8D7520A 994 $a 02 $b LUI 952 $l N5UX522 $d 20090701080000.0Initiate Another SILO Locator Search